How we can treat Sickle Cell Disease, Thalassemia and other Blood Disorders with Gene manipulation

Sickle cell disease (SCD) and thalassemia are among the most common inherited blood disorders, affecting millions of people globally.

CAR T-Cell Therapy: A New Frontier in Treating Solid Tumors

Chimeric Antigen Receptor (CAR) T-cell therapy has revolutionized treatment for hematologic malignancies like leukemia and lymphoma.

CRISPR-Cas is revolutionising Blood Cancer Treatment

Blood cancers, including leukemia, lymphoma, and myeloma, have long presented challenges to both patients and medical professionals

Indigenous CRISPR-Cas: Paving the Way for Affordable Cancer Treatment in India

Cancer remains a significant public health challenge in India, with the rising cost of treatment placing an immense burden on patients and their families